Caremark faced federal criminal and civil investigations arising from alleged violations of the Anti-Referral Payments Law, which prohibited certain payments to induce patient referrals. The company ultimately agreed to substantial settlements, including criminal fines, civil payments, and compliance obligations. Stockholders then brought a derivative action alleging that Caremark’s directors breached their fiduciary duties by failing adequately to monitor employees and corporate compliance. The case came before Chancellor Allen on a proposed settlement and required the court to assess whether the claims had enough possible merit to justify approving the settlement.
Can corporate directors be liable under Delaware law for breaching their duty of care by failing to monitor corporate employees or establish information and reporting systems that would alert them to legal violations?
Directors have a duty to attempt in good faith to assure that a corporation has an information and reporting system that is reasonably designed to provide senior management and the board with timely, accurate information sufficient to allow informed judgments concerning the corporation’s compliance with law and business performance. Director liability for a failure of oversight is among the most difficult theories in corporation law upon which a plaintiff might hope to win a judgment, and generally requires a sustained or systematic failure of the board to exercise oversight, such as an utter failure to attempt to assure a reasonable information and reporting system exists.
The court approved the settlement and explained that, although Delaware law recognizes a possible duty-of-oversight claim, the plaintiffs’ claims were weak because the record did not show the sort of sustained or systematic board failure necessary to impose liability. Caremark’s directors therefore were not shown likely to be personally liable on the facts presented.
Chancellor Allen reasoned that boards are not insurers against employee wrongdoing and that corporate legality cannot be guaranteed simply by board vigilance. The proper inquiry is whether the directors made a good-faith effort to put in place a reasonable system for reporting up information about legal compliance. Because the record did not indicate an utter failure to create such systems or a conscious disregard of known deficiencies, the likelihood of establishing liability was low. Even so, the settlement was fair because it produced governance reforms and some value in light of the substantial litigation risk facing the plaintiffs.
Caremark is the foundational Delaware oversight case and the source of the modern 'Caremark claim' for board-level monitoring failures. Its framework was later integrated into the fiduciary duty of loyalty and bad-faith doctrine in Stone v. Ritter, 911 A.2d 362 (Del. 2006), which adopted Caremark’s oversight standard and clarified that such claims require bad faith. It also influenced later oversight decisions, including Marchand v. Barnhill, 212 A.3d 805 (Del. 2019), which emphasized board-level monitoring of mission-critical compliance risks, and In re Citigroup Inc. Shareholder Derivative Litigation, 964 A.2d 106 (Del. Ch. 2009), which underscored how difficult it is to plead oversight liability for business-risk failures.
Enter a case name or citation — get a structured brief where every case it cites is checked against real law.
Try Law Student Workbench →